OBJECTIVE: To investigate the pathogenicity of a novel homozygous BRAT1 variant in 2 siblings with nonprogressive cerebellar ataxia (NPCA) through functional studies on primary and immortalized patient cell lines. METHODS: BRAT1 protein levels and ataxia-telangiectasia mutated (ATM) kinase activity in patient-derived and control cell lines were assessed by Western blotting. The impact of the novel BRAT1 variants on mitochondrial function was also assessed, by comparing patient and control cell lines for rates of oxygen consumption and for phosphorylation (S293) of the E1⍺ subunit of pyruvate dehydrogenase (PDH). RESULTS: Two male siblings with NPCA, mild intellectual disability, and isolated cerebellar atrophy were found to be homozygous for a c.185T>A (p.Val62Glu) variant in BRAT1 by whole exome sequencing. Western blotting revealed markedly decreased BRAT1 protein levels in lymphocytes and/or fibroblast cells from both affected siblings compared to control cell lines. There were no differences between the patient and control cells in ATM kinase activation, following ionizing radiation. Mitochondrial studies were initially suggestive of a defect in regulation of PDH activity, but there was no evidence of increased phosphorylation of the E1⍺ subunit of the PDH complex. Measurement of oxygen consumption rates similarly failed to identify differences between patient and control cells. CONCLUSIONS: Biallelic pathogenic variants in BRAT1 can be associated with NPCA, a phenotype considerably milder than previously reported. Surprisingly, despite the molecular role currently proposed for BRAT1 in ATM regulation, this disorder is unlikely to result from defective ATM kinase or mitochondrial dysfunction.

Division of Neurology School of Life Sciences University of Sussex Falmer Brighton UK

Zobrazit více v PubMed

Puffenberger EG, Jinks RN, Sougnez C, et al. . Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One 2012;7:e28936. PubMed PMC

Hanes I, Kozenko M, Callen DJ. Lethal neonatal rigidity and multifocal seizure syndrome—A misnamed disorder? Pediatr Neurol 2015;53:535–540. PubMed

Mundy SA, Krock BL, Mao R, Shen JJ. BRAT1-related disease—identification of a patient without early lethality. Am J Med Genet A 2016;170:699–702. PubMed

Srivastava S, Olson HE, Cohen JS, et al. . BRAT1 mutations present with a spectrum of clinical severity. Am J Med Genet A 2016;170:2265–2273. PubMed PMC

Fernández-Jaén A, Álvarez S, So EY, et al. . Mutations in BRAT1 cause autosomal recessive progressive encephalopathy: report of a Spanish patient. Eur J Paediatr Neurol 2016;20:421–425. PubMed PMC

Valence S, Cochet E, Rougeot C, et al. . Exome sequencing in congenital ataxia identifies two new candidate genes and highlights a pathophysiological link between some congenital ataxias and early infantile epileptic encephalopathies. Genet Med 2019;21:553–563. PubMed

Horn D, Weschke B, Knierim E, et al. . BRAT1 mutations are associated with infantile epileptic encephalopathy, mitochondrial dysfunction, and survival into childhood. Am J Med Genet A 2016;170:2274–2281. PubMed

Smith NJ, Lipsett J, Dibbens LM, Heron SE. BRAT1-associated neurodegeneration: intra-familial phenotypic differences in siblings. Am J Med Genet A 2016;170:3033–3038. PubMed

Aglipay JA, Martin SA, Tawara H, Lee SW, Ouchi T. ATM activation by ionizing radiation requires BRCA1-associated BAAT1. J Biol Chem 2006;281:9710–9718. PubMed

So EY, Ouchi T. BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction. BMC Cancer 2014;14:548. PubMed PMC

BRAT1 links Integrator and defective RNA processing with neurodegeneration